Federation Des Caisses Desjardins Du Quebec Crispr Therapeutics Ag Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.4 Billion
- Q4 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 1,863 shares of CRSP stock, worth $76,699. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,863
Previous 981
89.91%
Holding current value
$76,699
Previous $46,000
58.7%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding CRSP
# of Institutions
488Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$369 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$360 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$157 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$114 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.75MShares$113 Million1.21% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.21B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....